Avinger, Inc., was incorporated in Delaware on March 8, 2007. The company is a commercial-stage medical device company that designs, manufactures and sells real-time high-definition image-guided, minimally invasive catheter-based systems for physicians to treat patients with peripheral arterial disease (PAD). PAD patients have a large number of plaques in their arteries that supply blood to areas far from the heart, especially the pelvis and legs. The company's mission is to significantly improve the treatment of vascular diseases by launching products based on the Lumivascular platform, the only intravascular real-time high-definition image guidance system available in the market.
